Xanthatin inhibits STAT3 and NF-κB signalling by covalently binding to JAK and IKK kinases
Xanthatin inhibits STAT3 and NF-κB signalling by covalently binding to JAK and IKK kinases
复制标题
黄黄素通过与 JAK 和 IKK 激酶共价结合抑制 STAT3 和 NF-kappa B 信号传导
DOI:
10.1111/jcmm.14322
复制
发表时间:
2019-06-01
影响因子:
5.3
通讯作者:
Yu, Qiang
中科院分区:
文献类型:
--
作者:
Liu, Man;Xiao, Cheng-qian;Yu, Qiang
Aberrant activation of the signal transducer and activator of transcription 3 (STAT3) and the nuclear factor-kappa B (NF-kappa B) signalling pathways is associated with the development of cancer and inflammatory diseases. JAKs and IKKs are the key regulators in the STAT3 and NF-kappa B signalling respectively. Therefore, the two families of kinases have been the major targets for developing drugs to regulate the two signalling pathways. Here, we report a natural compound xanthatin from the traditional Chinese medicinal herb Xanthium L. as a potent inhibitor of both STAT3 and NF-kappa B signalling pathways. Our data demonstrated that xanthatin was a covalent inhibitor and its activities depended on its alpha-methylene-gamma-butyrolactone group. It preferentially interacted with the Cys243 of JAK2 and the Cys412 and Cys464 of IKK beta to inactivate their activities. In doing so, xanthatin preferentially inhibited the growth of cancer cell lines that have constitutively activated STAT3 and p65. These data suggest that xanthatin may be a promising anticancer and anti-inflammation drug candidate.